Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bawei Qinpi Wan
- Development stage
- Unknown
- Lead developer
- Xizang Ganlu Tibetan Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bawei Qinpi Wan is a traditional Tibetan medicine developed and manufactured by Xizang Ganlu Tibetan Medicine. It is an approved pharmaceutical product in China, registered under the National Drug License Number Z54020022. The formulation is primarily indicated for the treatment of various ophthalmic conditions, including conjunctivitis, keratitis, and early-stage cataracts. According to traditional Tibetan medical principles, the medicine functions to clear heat and improve eyesight. The formulation consists of eight primary ingredients: Cortex Fraxini (Qinpi), Terminalia chebula (Hezi), Terminalia bellirica (Maohezi), Phyllanthus emblica (Yuganzi), Punica granatum (Shiliuzi), Rubia tibetica (Zangqiancao), Bitumen (Zhaxungao), and Tourmaline (Bixi). It is administered orally in the form of pills.
- Brand names
- Ganlu
- Other names
- Bawei Qinpi Pills八味秦皮丸Bawei Qinpi Pill
Beyond the preview
Go deeper on Bawei Qinpi Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bawei Qinpi Wan.